Research institutions, pharmaceutical companies and biotechnology firms that are involved in genomics, molecular modelling and simulations are producing gigantic datasets that are growing at speed of light.
This explosion in genomic and proteomic information, especially from the latest Next-Gen Sequencers and the emergence of data-intensive molecular diagnostic techniques, demands a scalable, High Performance Computing infrastructure.